Eagle LogoPEPTIDE INITIATIVE

Peptide Database

Goals
Fat LossMuscle BuildingInjury HealingAnti-AgingCognitive EnhancementSleep OptimizationImmune SupportGut HealingSkin RejuvenationSexual Health
Peptides
5-Amino-1MQ
Weight Management
Abarelix
Hormone Support
Acetyl Hexapeptide-3 (Argireline)
Cosmetic
Adipotide
Weight Management
Adrenomedullin
Healing & Recovery
Alexamorelin
Growth Hormone
Angiotensin (1-7)
Healing & Recovery
AOD-9604
Weight Management
Apelin-13
Healing & Recovery
ARA-290 (Cibinetide)
Healing & Recovery
Bestatin (Ubenimex)
Immune
BPC-157
Healing & Recovery
Buserelin
Hormone Support
Cagrilintide
Weight Management
CagriSema
Weight Management
Capromorelin
Growth Hormone
Cartalax
Anti-Aging
Cathelicidin (hCAP-18 / Synthetic Derivatives)
Immune
Cerebrolysin
Cognitive
Cerluten
Cognitive
Cetrorelix
Hormone Support
Chonluten
Immune
CJC-1295 (No DAC)
Growth Hormone
CJC-1295 with DAC
Growth Hormone
Copper Tripeptide-1 (GHK-Cu)
Cosmetic
Cortexin
Cognitive
Crystagen
Immune
Daptomycin
Immune
Defensin (HBD-2)
Immune
Defensin (HBD-3)
Immune
Degarelix
Hormone Support
Dihexa
Cognitive
DSIP (Delta Sleep-Inducing Peptide)
Sleep & Recovery
Dulaglutide
Weight Management
Enalapril
Healing & Recovery
Epithalon
Anti-Aging
Exenatide
Weight Management
Fertirelin
Hormone Support
FOXO4-DRI
Anti-Aging
Ganirelix
Hormone Support
GHK-Cu (Copper Peptide)
Cosmetic
GHRH (1-29)
Growth Hormone
GHRP-2
Growth Hormone
GHRP-6 (Growth Hormone Releasing Peptide-6)
Growth Hormone
Glutathione
Anti-Aging
Gonadorelin (GnRH)
Hormone Support
Gramicidin
Immune
Hexarelin
Growth Hormone
Human Chorionic Gonadotropin (HCG)
Hormone Support
Human Growth Hormone (HGH)
Growth Hormone
IGF-1 LR3
Growth Hormone
Immunoxel (Dzherelo)
Immune
Imunofan
Immune
Intermedin (Adrenomedullin-2)
Healing & Recovery
Ipamorelin
Growth Hormone
Kisspeptin-10
Sexual Health
KPV (Alpha-MSH Fragment)
Healing & Recovery
Lactoferricin B
Immune
Larazotide
Healing & Recovery
Lentinan
Immune
Leuphasyl
Cosmetic
Leuphasyl
Cosmetic
Leuprolide
Hormone Support
Liraglutide
Weight Management
Livagen
Anti-Aging
Lixisenatide
Weight Management
LL-37
Immune
Macimorelin
Growth Hormone
Magainin-2
Immune
Mazdutide
Weight Management
Melanotan-2
Cosmetic
MK-677 (Ibutamoren)
Growth Hormone
MOTS-c
Metabolic
Myristoyl Pentapeptide-17
Cosmetic
N-Acetyl Selank
Cognitive
N-Acetyl Semax Amidate
Cognitive
NAD+
Mitochondrial
Nafarelin
Hormone Support
Natriuretic Peptide (ANP)
Healing & Recovery
Nesiritide (BNP)
Healing & Recovery
Nisin
Immune
Noopept (Omberacetam)
Cognitive
Orforglipron
Weight Management
Ovagen
Anti-Aging
Oxytocin Acetate
Hormone Support
P21 (P021)
Cognitive
PACAP-38
Healing & Recovery
Palmitoyl Oligopeptide
Cosmetic
Palmitoyl Pentapeptide-4 (Matrixyl)
Cosmetic
Palmitoyl Tetrapeptide-7
Cosmetic
Palmitoyl Tripeptide-1
Cosmetic
Pancragen
Metabolic
PEG-MGF
Healing & Recovery
Pemvidutide
Weight Management
Pentadecapeptide (BPC Analog)
Healing & Recovery
Pidotimod
Immune
Pinealon
Cognitive
PNC-27
Immune
Polymyxin B
Immune
Pralmorelin (GHRP-2)
Growth Hormone
Pramlintide
Weight Management
Prostamax
Hormone Support
PT-141 (Bremelanotide)
Sexual Health
Relaxin-2 (Serelaxin)
Healing & Recovery
Retatrutide
Weight Management
Selank
Cognitive
Semaglutide
Weight Management
Semax
Cognitive
Sermorelin
Growth Hormone
Setmelanotide
Weight Management
SLU-PP-332
Metabolic
SM-130686
Growth Hormone
Snap-8
Cosmetic
SS-31 (Elamipretide)
Mitochondrial
Substance P Antagonists
Healing & Recovery
Survodutide
Weight Management
SYN-AKE
Cosmetic
Tabimorelin
Growth Hormone
TB-500
Healing & Recovery
Tesamorelin
Growth Hormone
Testagen
Hormone Support
Thymalin
Immune
Thymopentin (TP-5)
Immune
Thymopoietin
Immune
Thymosin Alpha-1
Immune
Thymosin Beta-4
Healing & Recovery
Thymulin (FTS)
Immune
Thymulin Analog (PAT)
Healing & Recovery
Tirzepatide
Weight Management
Tripeptide-29
Cosmetic
Triptorelin
Hormone Support
Ularitide
Healing & Recovery
Urocortin
Healing & Recovery
Ventfort
Anti-Aging
Vesilute
Hormone Support
Vilon
Immune
VIP (Vasoactive Intestinal Peptide)
Healing & Recovery
Xenin-25
Metabolic
Ziconotide (Prialt)
Healing & Recovery
Total Peptides: 139
Back to Home

Melanotan-2

A synthetic copy of the hormone that switches on tanning.

Small human trials found it darkened skin without sun exposure and triggered erections in men with erectile dysfunction. It has never been approved by any regulator.

Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards

CosmeticLimited human trialsNot FDA approved

Suggested dose

0.25 – 0.5 mg

Once dailyCycle: 4-6 weeksOnset: Moderate (1-2 weeks)
No human value published. In mice, plasma clearance after injection was rapid; no human pharmacokinetic study located.Half-life
Completely absorbed by subcutaneous injection in humans for the related peptide melanotan-I; not separately measured for melanotan-II in humansBioavailability
1024.18 g/molMolecular weight
Limited human trialsEvidence level

Compound profile

Scientific & efficacy data

Cosmetic

Peptide profile

Tanning Efficacy9.5
Sexual Function8.8
Tan Longevity8.5

Limited human trials

Melanotan-2

0.25 mg (250 mcg) · Once daily

Molecular formula

C50H69N15O9

Mol. weight
1024.18 g/mol
CAS number
121062-08-6
PubChem
92432
Developed · 1991
Victor J. Hruby and Mac E. Hadley
University of Arizona

Amino acid sequence

Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2

Tanning Efficacy

Increased skin colour in 2 of 3 healthy men in the only published tanning trial, measured both by a reflectance instrument and by eye, one week after 5 subcutaneous doses [1]. No larger tanning trial has been published.

Sexual Function

Erections without any sexual stimulation in 17 of 20 men with erectile dysfunction across placebo-controlled crossover trials [4]. In the psychogenic group, tip rigidity above 80% averaged 38.0 minutes versus 3.0 minutes on placebo (p=0.0045) [6]. Reported sexual desire rose after about 7 in 10 melanotan-2 doses (13 of 19, 68%) versus about 2 in 10 placebo doses (4 of 21, 19%) [4].

Tan Longevity

In the only trial that measured how long colour lasts, increased pigmentation was still present in 2 of 3 men one week after dosing stopped [1]. Persistence beyond that is community-reported and has not been measured in any published melanotan-2 trial.

Dosing

How much do I take?

0.25 – 0.5 mg

0.25 – 0.5 mg

Full Melanotan-2 dosing protocol

Covers all 3 documented dose levels · timing · dose-adjustment guidance.

Melanotan-2Once daily

How much peptide is in your bottle?

Look at the label on the vial. It’s the number next to mg — like "5 mg".

Type a number to continue.
0

Suitability

Is this right for me?

Best for achieving a natural-looking tan & reducing sun exposure time

Best for

Fair-Skinned Individuals Who Struggle to Tan

If you're the type who burns before you bronze, MT-2 can be a game-changer. It works by telling your skin cells to produce more melanin—the pigment that creates a tan. People who normally can't tan often see the most dramatic results.

Those Wanting to Reduce Sun Exposure

MT-2 means you need far less UV exposure to develop and maintain a tan. A few minutes of sun or a brief tanning bed session goes much further. This could potentially reduce your cumulative UV damage over time.

Year-Round Tan Maintenance

Unlike a natural tan that fades quickly, MT-2 tans last longer and can be maintained year-round with minimal upkeep. Many users find they can keep their summer color through winter with just weekly maintenance doses.

Those Experiencing Low Libido

MT-2 has significant effects on sexual arousal and function in both men and women. While PT-141 is more targeted for this purpose, some users appreciate getting tanning and libido benefits from one peptide.

Consider alternatives if

Tanning without injectionNasal spray formulations (less effective), Traditional sun tanning, Spray tans and self-tanners, Gradual tanning lotions
Sexual health benefits onlyPT-141 (Bremelanotide), Kisspeptin-10, Lifestyle modifications
Skin protection and healthGHK-Cu, Broad-spectrum sunscreen, Antioxidant supplements, Vitamin D

Do not use if

You have a personal or family history of melanoma—MT-2 stimulates melanocytes, and the effects on pre-existing abnormal cells are unknownYou have numerous atypical (dysplastic) moles—these need monitoring, not stimulationYou are pregnant or breastfeeding—effects on fetal development are unknownYou have severe heart conditions—MT-2 can temporarily raise blood pressureYou've had allergic reactions to peptides in the pastYou have Addison's disease or other adrenal disorders

Use with caution if

You take blood pressure medications—MT-2 can affect cardiovascular functionYou use erectile dysfunction drugs—combining with MT-2 may cause dangerous prolonged erectionsYou have many moles—get a baseline skin check first and monitor regularlyYou have a history of priapism—MT-2 can trigger prolonged erectionsYou're taking immunosuppressant medications—effects on immune function are unclearYou have autoimmune skin conditions—response to increased pigmentation is unpredictable

Not sure?

Compare Melanotan-2 with similar peptides to find the best fit for your goals.

Administration

How do I use it?

Subcutaneous injection · Nasal spray

Route

Subcutaneous injection (just under the skin)—this is the most common and effective method for MT-2

Best sites

Belly fat area (1-2 inches from belly button)—most popular siteFront or outer thigh (middle section)Back of the upper arm (if you can reach)

Covers reconstitution · step-by-step technique · storage · a sample daily schedule.

Safety

Is it safe?

5 common side effects · 3 serious

Human safety data for melanotan-2 comes from small trials totalling about 23 men, plus a handful of published case reports.

In the phase-I study of 3 healthy men, mild nausea was reported at most dose levels, and the 0.03 mg/kg dose caused grade II drowsiness and fatigue in 1 of the 2 men who reached it — which is why 0.025 mg/kg was the dose carried forward [1].

Across 20 men with erectile dysfunction given 0.025 mg/kg, severe nausea occurred in about 1 in 8 (12.9%) [4].

In the psychogenic erectile-dysfunction trial, nausea, stretching and yawning, and reduced appetite were each more common on melanotan-2 than on placebo, though none required treatment [6].

Beyond the trials, single case reports describe rhabdomyolysis (muscle breakdown that can injure the kidneys) after a 6 mg injection [9], ischaemic priapism needing surgery [10], melanoma in a 20-year-old woman who used it alongside sunbeds [8], and mucosal melanoma in a 22-year-old woman who used a nasal spray version [11].

A case report shows that something happened in one person; it cannot show how often it happens.

Melanotan-2 was developed at the University of Arizona [2][3]. The published human evidence is small: a phase-I study in 3 healthy men [1] and erectile-dysfunction crossover trials totalling 20 men [4][6][7]. No published trial dosed for longer than two weeks [1].

No human pharmacokinetic study was located — searches across PubMed, the full PubChem record and ClinicalTrials.gov returned melanotan-2 data only in rats, mice and rabbits, with human pharmacokinetics available only for the related peptide melanotan-1.

One registered phase 2 trial, testing it alongside narrowband UV-B light for vitiligo, began recruiting in February 2026 and has posted no results [12]. Long-term skin-cancer risk has never been tested in a trial; what exists on that question is case reports [8][11].

Common side effects · experienced by some users

  • Facial flushing

    Your face may turn red and feel warm shortly after injection. This is one of the most common effects, especially in the first week. It's caused by MT-2's effects on blood vessels.

    Management: Usually subsides within 30-60 minutes. Taking MT-2 before bed helps. Flushing typically decreases significantly after the first week as your body adjusts.

  • Nausea

    Many users feel queasy after injection, especially at higher doses or during the first week. This is the most common reason people struggle with MT-2.

    Management: Start with lower doses (100-150 mcg) and work up. Take before bed to sleep through it. A light snack beforehand may help. Anti-nausea medications can be used if needed.

  • Darkening of moles and freckles

    Existing moles, freckles, and any pigmented areas will darken along with your skin. This is expected but needs monitoring.

    Management: Get a baseline skin check before starting. Monitor moles for any changes in size, shape, or color. See a dermatologist if any mole looks concerning.

  • Spontaneous erections (men)

    MT-2 activates the same pathways as PT-141, so increased erections are common, especially during the loading phase.

    Management: Usually decreases as your body adjusts. If problematic, reduce dose. Never combine with ED medications like Viagra—risk of priapism.

  • Drowsiness and fatigue

    Many people feel tired or drowsy after injection, likely related to MT-2's effects on the nervous system.

    Management: This is why evening dosing is recommended. Use it to your advantage—inject before bed and let it work while you sleep.

Less common

New mole formationHeadaches

These typically resolve with continued use or dose adjustment.

Stop and seek help if

  • Any mole shows concerning changes (growth, irregular borders, color changes, bleeding)
  • You develop new moles that appear atypical or concerning
  • Nausea or flushing remains severe beyond the first week
  • You experience priapism or prolonged erection
  • Any signs of allergic reaction (difficulty breathing, significant swelling)
  • You've achieved your desired tan and completed your cycle

Melanotan-2 is not FDA approved and is considered a research compound. The long-term effects on skin cancer risk are not definitively known. Regular dermatological monitoring is essential for anyone using MT-2. This information is educational only—consult a healthcare provider before use.

With other peptides

  • Caution:PT-141 (Bremelanotide) — Both act on melanocortin receptors. Don't use on the same day—effects may compound unpredictably. PT-141 is more targeted for sexual function.
  • Safe:BPC-157 — No known interaction. Can be used together safely for general wellness benefits. Inject at different sites.
  • Safe:GHK-Cu — Safe combination. GHK-Cu supports skin health through different mechanisms, complementing MT-2's tanning effects.
  • Safe:Growth hormone peptides — Generally safe to combine. Separate injection times by at least 30 minutes.

With medications

  • Caution:Erectile dysfunction drugs (Viagra, Cialis, Levitra) — NEVER combine—serious risk of priapism (dangerous prolonged erection). Wait at least 24-48 hours between MT-2 and ED medications.
  • Caution:Blood pressure medications — MT-2 can temporarily affect blood pressure. Monitor BP closely and inform your doctor about MT-2 use.
  • Caution:Antidepressants (SSRIs) — Potential for interaction affecting sexual side effects. Use with caution and monitor your response.
  • Safe:Antihistamines — Some antihistamines may help with nausea and flushing. Generally safe to combine.

With supplements

  • Safe:Vitamin D — Safe and potentially beneficial. Vitamin D supports skin health and you'll need less sun exposure with MT-2.
  • Safe:Antioxidants (Vitamin C, E) — Safe to combine. May offer additional skin protection.
  • Safe:Tyrosine is a melanin precursor. Some believe it enhances MT-2 results, though this isn't proven. Safe to take together.
  • Safe:Ginger or anti-nausea supplements — Can help manage MT-2-induced nausea during the loading phase.

Effectiveness

How do I know it's working?

Limited human trials · first signs days 1-5

Evidence level

Limited human trials

60/100

Regulatory status

Not FDA approved

Onset of effects

Moderate

(1-2 weeks)

How it works

Your skin color comes from a pigment called melanin, produced by cells called melanocytes.

When you tan naturally, UV rays tell these cells to make more melanin to protect your skin. Melanotan-2 is like a shortcut—it mimics your body's natural 'make more melanin' signal (called alpha-MSH) but is much more powerful and long-lasting.

When you inject MT-2, it activates receptors on your melanocytes, telling them to ramp up melanin production. You still need a little bit of UV to 'show' the color, but far less than normal tanning.

The same receptors that control skin color also happen to affect libido and appetite, which is why MT-2 has those additional effects.

The deeper mechanism

Melanotan-2 is a synthetic cyclic heptapeptide built from alpha-melanocyte-stimulating hormone (alpha-MSH), the body's own pigment signal. It activates melanocortin receptors MC1R through MC5R without selecting between them [3].

The tanning effect runs through MC1R on melanocytes, the pigment-making cells in skin. Switching that receptor on raises cyclic AMP inside the cell, and that rise is the signal that turns up tyrosinase and the other melanin-making enzymes, increasing eumelanin, the darker pigment.

That receptor pathway was mapped in cultured human melanocytes using alpha-MSH itself rather than melanotan-2 [5].

The effect on erection is documented directly in people: melanotan-2 produced erections without any sexual stimulation in 17 of 20 men with erectile dysfunction, which points to an action in the brain and spinal cord rather than on the penis itself [4].

The work locating which melanocortin receptors carry that signal, and the appetite-suppressing signal, was done in rats, not in people [3].

The D-phenylalanine substitution this family of analogues carries makes them resist being broken down by enzymes in blood, which is why they act longer than natural alpha-MSH. That was shown for the parent analogue in frog skin and mouse melanoma cells, not in humans [2].

How long melanotan-2 itself lasts in a person has never been measured: no human pharmacokinetic study has been published, and in mice, clearance from the blood after injection was rapid.

What to expect

  1. Days 1-5

    What you might notice

    • Facial flushing shortly after injection (very common)
    • Nausea that may last 30-60 minutes (common)
    • Feeling tired or drowsy (take at bedtime!)
    • Increased libido or spontaneous erections (men)
    • Little to no visible tan yet—melanin is building up

    What's normal

    • Flushing and nausea are common and usually decrease by day 5-7
    • Some people feel nothing at all initially
    • Existing freckles and moles may start darkening first

    What's next

    • Continue daily dosing during loading phase
    • Get brief UV exposure (10-15 min) every few days to activate melanin
    • Side effects typically improve significantly after the first week
  2. Weeks 1-2

    What you might notice

    • Visible tan starting to develop, especially on sun-exposed areas
    • Moles and freckles noticeably darker
    • Side effects decreasing significantly
    • Enhanced libido effects becoming apparent
    • Possible slight appetite suppression

    What's normal

    • Tan develops gradually, not overnight
    • Different body areas may tan at different rates
    • Face and arms often show color first

    What's next

    • Continue daily dosing until you reach desired color
    • Regular brief UV exposure speeds results
    • Monitor moles for any concerning changes
  3. Weeks 3-4 and beyond

    What you might notice

    • Your tan reaching its peak depth
    • Very minimal side effects at this point
    • Color appearing on areas that rarely get sun
    • Long-lasting tan that fades very slowly

    What's normal

    • You may have reached your genetic tanning potential
    • Side effects should be minimal or gone
    • Tan persists well between doses

    What's next

    • Switch to maintenance dosing (2-3 times per week)
    • Occasional UV exposure maintains color
    • Many users maintain year-round tan with just weekly doses

Signs it's working

Tanning Response

  • Gradual darkening of skin, especially sun-exposed areas
  • Freckles and moles becoming darker
  • Tan developing faster than normal with UV exposure
  • Tan lasting longer and fading more slowly
  • Even areas that rarely get sun developing some color

Sexual Health Effects

  • Increased libido or sexual interest
  • Improved erectile response (men)
  • Enhanced arousal (women)
  • Spontaneous erections (men)—indicates the peptide is active

Other Effects

  • Reduced appetite (common side effect that some find beneficial)
  • Decreased side effects over time (shows adaptation)
  • Consistent results with maintenance dosing

Not seeing results? Common reasons

  • Not getting any UV exposure—MT-2 produces melanin but you need some UV to 'activate' it and see the tan
  • Degraded peptide from improper storage—check if solution is clear and properly refrigerated
  • Dose too low—some people need the full 500mcg to see results
  • Unrealistic expectations—MT-2 won't make you darker than your genetic potential allows
  • Not enough time—full results take 2-4 weeks of consistent loading
  • Poor quality peptide from unreliable source—always verify with third-party testing (COA)

Key research

1996[1]
“Evaluation of melanotan-II, a superpotent cyclic melanotropic peptide, in a pilot phase-I clinical study”Dorr RT, Lines R, Levine N, Brooks C, Xiang L, Hruby VJ, Hadley MEFinding: Pilot phase-I human study: subcutaneous melanotan-II induced measurable skin tanning in healthy male volunteers after only 5 low doses (every other day), with pigmentation increasing in the face, upper body and buttocks. 0.025 mg/kg/day was recommended for subsequent phase-I work. Confirms MT-II induces UV-independent tanning in humans.View study
1980[2]
“4-Norleucine, 7-D-phenylalanine-alpha-melanocyte-stimulating hormone: a highly potent alpha-melanotropin with ultralong biological activity”Sawyer TK, Sanfilippo PJ, Hruby VJ, Engel MH, Heward CB, Burnett JB, Hadley MEFinding: The foundational research that led to MT-2 development showed that synthetic MSH analogs could be far more potent than natural hormones at stimulating melanin production. This work at the University of Arizona laid the groundwork for all tanning peptides.View study
2006[3]
“Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization”Hadley ME, Dorr RTFinding: This comprehensive review documented MT-2's effects on tanning, sexual function, and appetite across multiple studies. The authors noted its potential for treating various conditions while also highlighting the need for more long-term safety research.View study
2000[4]
“Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II”Wessells H, Levine N, Hadley ME, Dorr R, Hruby VFinding: Pooled human results from 20 men with psychogenic or organic erectile dysfunction, given melanotan-II subcutaneously in double-blind, placebo-controlled crossover studies. Erections occurred in 17 of the 20 men without any sexual stimulation, with a mean of 41 minutes of recorded tip rigidity above 80%. Increased sexual desire was reported after 13 of 19 melanotan-II doses (68%) versus 4 of 21 placebo doses (19%) (p<0.01). At the 0.025 mg/kg dose, severe nausea occurred in 12.9% of subjects.View study
1999[5]
“Participation of the melanocortin-1 receptor in the UV control of pigmentation”Suzuki I, Im S, Tada A, Scott C, Akcali C, Davis MB, Barsh G, Hearing V, Abdel-Malek ZFinding: Laboratory work in cultured human melanocytes (pigment-making skin cells): switching on the melanocortin-1 receptor raises cyclic AMP inside the cell, which is the main signal that starts melanin production. Treating human melanocytes with alpha-MSH increased eumelanin, the darker pigment. This is the receptor pathway melanotan-II acts on, though this study tested alpha-MSH and ultraviolet light rather than melanotan-II itself.View study
1998[6]
“Synthetic melanotropic peptide initiates erections in men with psychogenic erectile dysfunction: double-blind, placebo controlled crossover study”Wessells H, Fuciarelli K, Hansen J, Hadley ME, Hruby VJ, Dorr R, Levine NFinding: Double-blind, placebo-controlled crossover trial in 10 men with erectile dysfunction of no known organic cause. Clinically apparent erections developed in 8 of the 10 men. Mean duration of tip rigidity above 80% was 38.0 minutes on melanotan-II versus 3.0 minutes on placebo (p=0.0045). Nausea, stretching and yawning, and decreased appetite were reported more often on melanotan-II than on placebo, but none required treatment. The dose was 0.025 mg/kg subcutaneously.View study
2000[7]
“Effect of an alpha-melanocyte stimulating hormone analog on penile erection and sexual desire in men with organic erectile dysfunction”Wessells H, Gralnek D, Dorr R, Hruby VJ, Hadley ME, Levine NFinding: Double-blind, placebo-controlled crossover in ten men with organic erectile dysfunction. MT-II 0.025 mg/kg subcutaneous produced RigiScan-recorded erections after 12 of 19 injections versus 1 of 21 placebo doses; mean rigidity score among responders was 6.9 of 10, and reported sexual desire was significantly higher than placebo.View study
2014[8]
“Melanoma associated with the use of melanotan-II”Hjuler KF, Lorentzen HFFinding: Case report: histologically confirmed cutaneous melanoma in a 20-year-old woman (Fitzpatrick type II) whose MT-II use in combination with tanning-bed exposure coincided with the lesion's development. One of several published reports of melanoma or eruptive atypical nevi arising during melanotropic peptide use.View study
2012[9]
“Melanotan II injection resulting in systemic toxicity and rhabdomyolysis”Nelson ME, Bryant SM, Aks SEFinding: Case report in one 39-year-old man: a 6 mg subcutaneous self-injection was followed by sympathomimetic toxicity (heart rate peaking at 146 beats per minute), rhabdomyolysis with creatine kinase rising to 17,773 IU/L, and kidney dysfunction (creatinine 2.25 mg/dL), requiring a three-day intensive-care admission. The report describes this as six times the starting dose the patient believed was recommended, and it is roughly three times the 0.025 mg/kg dose used in the clinical trials (about 1.75 mg for a 70 kg adult). The injected substance was confirmed as melanotan-II by mass spectrometry.View study
2021[10]
“Melanotan tanning injection: a rare cause of priapism”Mallory CW, Lopategui DM, Cordon BHFinding: Case report: ischemic priapism after a 2 mg subcutaneous MT-II injection, refractory to maximal intracavernosal phenylephrine and requiring penoscrotal decompression. At least three peer-reviewed priapism cases after MT-II injection have been published (2013, 2019, 2021).View study
2025[11]
“Melanotan II nasal spray: a possible risk factor for oral mucosal malignant melanoma?”Yassin Alsabbagh A, Bhujel N, Singh RPFinding: Case report in one 22-year-old woman who used a melanotan-II nasal spray for tanning and developed a mass in the upper front jaw. Tissue analysis confirmed mucosal malignant melanoma, a cancer of the moist lining of the mouth. She had surgery followed by ongoing immunotherapy. This is the only peer-reviewed report found on the nasal route, and it describes harm rather than effectiveness: no trial has tested melanotan-II as a nasal spray.View study
2026[12]
“A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Melanotan II as an Adjunct to Narrowband UV-B Phototherapy in Adults With Stable Nonsegmental Vitiligo (NCT07437560)”ClinicalTrials.gov registry recordFinding: Registered clinical trial, recruiting since 2 February 2026. This is a randomised, double-blind, placebo-controlled phase 2 study testing melanotan-II alongside narrowband UV-B light treatment in adults with stable nonsegmental vitiligo, a condition where patches of skin lose their colour. No results have been posted yet, so nothing about how well it works or how safe it is can be drawn from it. It is listed here because it is the only registered melanotan-II trial found on ClinicalTrials.gov.View study

Clinical trials

Tested in people

1 registered study, 1 still enrolling.

1registered studies
1recruiting now
0phase 3 or 4
0with published results

By phase

Phase 21

A trial spanning two phases is counted in both, so these can sum above the total. Observational studies carry no phase.

What kind of research

Gave the drug1
Records only0

About 60 people took part in the studies that actually administered Melanotan-2. Observational studies analyse the records of people already taking it — nobody was given anything for the study, so they are counted separately and cannot show cause and effect.

Most recent

  • NCT07437560Phase 2Recruiting60 enrolled

    Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

    Hudson Biotech

See all 1 trial for Melanotan-2

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered twice is counted once. A study is counted when Melanotan-2 is named as an intervention; studies that only mention it in passing are not.

Questions

Frequently asked

Do I still need sun exposure with Melanotan-2?

Yes, but much less than normal. MT-2 increases melanin production, but some UV exposure helps 'activate' and darken the melanin. Most users find 10-20 minutes of sun or a short tanning bed session every few days is enough. The good news is you're getting tan with far less UV exposure than traditional tanning.

Will MT-2 work on very fair skin that normally burns?

Actually, this is where MT-2 shines most dramatically. People with fair skin who normally burn before they tan often see the most impressive results. MT-2 helps your skin produce the protective melanin that you'd normally struggle to make. However, you're still increasing your genetic melanin capacity—you won't become as dark as someone with naturally dark skin.

Is the tan from MT-2 different from a natural tan?

The tan is real melanin, just like a natural tan. However, MT-2 tans tend to have a slightly different hue—some describe it as a bit more 'warm' or 'golden.' The tan also lasts much longer than a natural tan because your skin is actively maintaining higher melanin levels, not just responding to UV damage.

Why does MT-2 cause nausea and how can I reduce it?

MT-2 activates receptors throughout your body, including in areas that affect nausea. The good news: it almost always improves after the first week as your body adjusts. Tips to reduce it: start with lower doses (100-150mcg), inject before bed, take with a light snack, and stay hydrated. Ginger supplements can help too.

Can women use Melanotan-2?

Absolutely. MT-2 works the same way for both sexes when it comes to tanning. Women may experience enhanced libido as a side effect, similar to men. The main considerations are the same: avoid during pregnancy/breastfeeding and monitor moles regularly.

Will my existing moles become dangerous?

MT-2 will darken existing moles and freckles—that's expected. There's no conclusive evidence that MT-2 causes melanoma, but the honest answer is we don't know the long-term effects. Anyone using MT-2 should get a baseline skin check before starting and regular follow-ups. Stop immediately if any mole changes shape, size, or color in concerning ways.

How long does an MT-2 tan last?

Much longer than a natural tan. With maintenance dosing (once or twice weekly), many users maintain their tan year-round. If you stop completely, the tan will gradually fade over 1-2 months, but this is slower than a natural tan fading because your body has genuinely increased melanin production.

Can I use MT-2 with self-tanner?

Yes, you can combine them. MT-2 creates real melanin (a biological tan), while self-tanners create surface color (DHA reacting with dead skin cells). Some people use self-tanner while waiting for MT-2 to kick in during the loading phase. Just be aware that moles darkened by MT-2 won't be covered by self-tanner.

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for Melanotan-2, on one page.

Medical disclaimer

Melanotan-2 is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Sep 2, 2026